Jane C. Sterling
Research Subjects
Jane C. Sterling has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Robert Thompson
Doctoral Programme in Clinical Psychology, Cardiff & Vale University Health Board & School of Psychology, Cardiff University , Cardiff, Wales
1 shared publication - Anthony Bewley
Barts Health NHS Trust and Queen Mary University
1 shared publication Cameron Davies-Husband
Department of Otorhinolaryngology, Cambridge University Hospitals NHS Foundation Trust (CUHT), UK
1 shared publication- Chenxi Wang
British Association of Dermatologists , Willan House, London
1 shared publication - George W. M. Millington
Dermatology Department, Norfolk and Norwich University Hospital , Norwich
1 shared publication Hassan Mohammed
Barts Health NHS Trust, London, UK
1 shared publication
Latest Publications
- Open Access
- 5 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1035-1045
British Association of Dermatologists living guideline for managing people with nodular prurigo (prurigo nodularis) 2025
Lay Summary: Nodular prurigo (NP) is a chronic skin condition. Lesions can be either single or widespread on the body. Thus, it can have a negative impact on a person’s quality of life. The exact cause of NP is unknown, as several mechanisms play a role. These mechanisms sometimes overlap between physical and brain–behavioural elements. Dermatologists diagnose NP based on a history of long-lasting itching and scratching. A Guideline Development Group met to produce a new guideline for treating people with NP. The group included consultant dermatologists, a psychotherapist, dermatology trainees, a general practitioner and people with lived experience of NP. The group identified and reviewed the current literature on treating NP. They discussed the findings at length before producing a set of recommendations. The guideline will provide up-to-date management guidance for healthcare practitioners. Initial steps included taking a full history and examination of patients. This included causes of itch, patient education and reversing the itch–scratch habit. The first treatment option is usually topical therapy (applied to the skin). If this fails, other options include phototherapy and oral medications. Further treatments include nonsedating antihistamines and low-dose antidepressants. Steroid injections or cryotherapy (freezing with liquid nitrogen) are options for single lesions. The guideline provides recommendations for treating people with NP. It also includes recommendations for future research and audit points for hospitals. A patient information leaflet is available on the British Association of Dermatologists’ website (https://www.skinhealthinfo.org.uk/condition/nodular-prurigo).
- 5 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1035-1045
Open AccessBritish Association of Dermatologists living guideline for managing people with nodular prurigo (prurigo nodularis) 2025
Lay Summary: Nodular prurigo (NP) is a chronic skin condition. Lesions can be either single or widespread on the body. Thus, it can have a negative impact on a person’s quality of life. The exact cause of NP is unknown, as several mechanisms play a role. These mechanisms sometimes overlap between physical and brain–behavioural elements. Dermatologists diagnose NP based on a history of long-lasting itching and scratching. A Guideline Development Group met to produce a new guideline for treating people with NP. The group included consultant dermatologists, a psychotherapist, dermatology trainees, a general practitioner and people with lived experience of NP. The group identified and reviewed the current literature on treating NP. They discussed the findings at length before producing a set of recommendations. The guideline will provide up-to-date management guidance for healthcare practitioners. Initial steps included taking a full history and examination of patients. This included causes of itch, patient education and reversing the itch–scratch habit. The first treatment option is usually topical therapy (applied to the skin). If this fails, other options include phototherapy and oral medications. Further treatments include nonsedating antihistamines and low-dose antidepressants. Steroid injections or cryotherapy (freezing with liquid nitrogen) are options for single lesions. The guideline provides recommendations for treating people with NP. It also includes recommendations for future research and audit points for hospitals. A patient information leaflet is available on the British Association of Dermatologists’ website (https://www.skinhealthinfo.org.uk/condition/nodular-prurigo).
- 20 November 2019
- Published by Wiley
- p. 624-648
Poxvirus Infections
- 1 June 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (6) , 1284
Polyomaviruses – be aware, be very aware
- 1 June 2019
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (6) , 1284
Polyomaviruses – be aware, be very aware
- 1 November 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 67, 141-151
CD8 + T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer
- 1 November 2016
- Published by Elsevier in European Journal of Cancer
- Vol. 67, 141-151
CD8 + T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer